CTT-2274

N/A

Report date: 2025/03/04 09:31:42
NME

Base Information

Drug NameCTT-2274
Drug Alias NameCTT-2274CTT2274
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstate-Specific Membrane Antigen modulatorsTubulin polymerisation inhibitors
TargetsProstate-Specific Membrane AntigenTubulin
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCancer Targeted Technology Llc
China Registration ClassN/A

Develop Information

Active CompaniesCancer Targeted Technology Llc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A